Multi-Plate Irradiation to Speed Cellular Catalyst Research in Drug Discovery, Biochemistry
PENNSBURG, Pa., June 16, 2022 /PRNewswire-PRWeb/ — Acceled LLC, providers of benchtop instruments designed for chemists and researchers seeking to accelerate chemical reactions using photoredox catalysis, announces today the introduction of the cLight. The cLight joins the Acceled Photoreactor product line to add versatility and functionality for biochemists. The cLight, ideal for drug discovery and university research, allows for:
Acceled’s expanded product line now supports growth plates as well as vial sizes GC, 4, 8, 30, and 40 ml. This increased versatility and compact footprint allow for expanded experiment design and fit:
Biochemistry research must ramp up to meet the demands for innovation in genetic research, pharmaceuticals, proteomics, diagnostics, and food science. Acceled’s Photoreactor m2 and new cLight instruments support these aggressive innovation pipelines.
Prominent universities and top pharmaceutical companies around the world rely on Acceled’s photoreactor platform. The cLight is now available for order at acceledbio.com/cLight.
ABOUT ACCELED
The scientists and engineers behind Acceled are focused on bringing novel photocatalysis technology and products to researchers seeking to accelerate chemical reactions using photoredox catalysis. Their best-in-class tools support researchers and scientists dedicated to solving real-world challenges in drug discovery, pharma, proteomics, and basic material research. Learn more at https://www.acceledbio.com/.
Media Contact
Alison Arnold, Launch Team Inc, 1 (585) 256-1640, alison@launchteaminc.com
SOURCE Acceled
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…